AMALGAMATED BANK - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26
-16.1%
24,3960.0%0.00%
Q2 2023$31
-3.1%
24,396
+1.9%
0.00%
Q1 2023$32
-22.0%
23,937
-13.1%
0.00%
Q4 2022$41
-99.9%
27,5570.0%0.00%
Q3 2022$33,000
+6.5%
27,557
+1.6%
0.00%
Q2 2022$31,000
-62.7%
27,116
-2.5%
0.00%
-100.0%
Q1 2022$83,000
-48.1%
27,816
-53.9%
0.00%0.0%
Q4 2021$160,000
+44.1%
60,330
+97.1%
0.00%0.0%
Q3 2021$111,000
-20.7%
30,608
-5.1%
0.00%0.0%
Q2 2021$140,000
+55.6%
32,265
+22.4%
0.00%
-66.7%
Q1 2021$90,000
-2.2%
26,3640.0%0.00%0.0%
Q4 2020$92,000
+46.0%
26,364
+0.3%
0.00%0.0%
Q3 2020$63,000
+28.6%
26,275
-2.2%
0.00%
+50.0%
Q2 2020$49,000
+6.5%
26,878
-9.1%
0.00%
+100.0%
Q1 2020$46,000
-28.1%
29,574
-0.4%
0.00%0.0%
Q4 2019$64,000
+16.4%
29,707
+0.8%
0.00%0.0%
Q3 2019$55,000
-29.5%
29,468
-0.8%
0.00%
-50.0%
Q2 2019$78,000
+18.2%
29,714
+16.2%
0.00%0.0%
Q1 2019$66,000
+15.8%
25,571
+3.6%
0.00%0.0%
Q4 2018$57,000
+62.9%
24,692
+128.4%
0.00%
+100.0%
Q3 2018$35,000
-50.0%
10,809
-56.4%
0.00%
-50.0%
Q2 2018$70,0000.0%24,790
+26.1%
0.00%0.0%
Q1 2018$70,000
-10.3%
19,659
-2.2%
0.00%0.0%
Q4 2017$78,000
+90.2%
20,098
+25.4%
0.00%
+100.0%
Q3 2017$41,000
+2.5%
16,029
+8.7%
0.00%0.0%
Q2 2017$40,000
-14.9%
14,747
+3.0%
0.00%
-50.0%
Q1 2017$47,000
+62.1%
14,316
+16.2%
0.00%
+100.0%
Q4 2016$29,00012,3250.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders